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Abstract
Environmental factors and host genetics interact to control the gut microbiota, which may have a role in the development
of obesity and insulin resistance. TLR2-deficient mice, under germ-free conditions, are protected from diet-induced insulin
resistance. It is possible that the presence of gut microbiota could reverse the phenotype of an animal, inducing insulin
resistance in an animal genetically determined to have increased insulin sensitivity, such as the TLR2 KO mice. In the present
study, we investigated the influence of gut microbiota on metabolic parameters, glucose tolerance, insulin sensitivity, and
signaling of TLR2-deficient mice. We investigated the gut microbiota (by metagenomics), the metabolic characteristics, and
insulin signaling in TLR2 knockout (KO) mice in a non-germ free facility. Results showed that the loss of TLR2 in
conventionalized mice results in a phenotype reminiscent of metabolic syndrome, characterized by differences in the gut
microbiota, with a 3-fold increase in Firmicutes and a slight increase in Bacteroidetes compared with controls. These
changes in gut microbiota were accompanied by an increase in LPS absorption, subclinical inflammation, insulin resistance,
glucose intolerance, and later, obesity. In addition, this sequence of events was reproduced in WT mice by microbiota
transplantation and was also reversed by antibiotics. At the molecular level the mechanism was unique, with activation of
TLR4 associated with ER stress and JNK activation, but no activation of the IKKb-IkB-NFkB pathway. Our data also showed
that in TLR2 KO mice there was a reduction in regulatory T cell in visceral fat, suggesting that this modulation may also
contribute to the insulin resistance of these animals. Our results emphasize the role of microbiota in the complex network of
molecular and cellular interactions that link genotype to phenotype and have potential implications for common human
disorders involving obesity, diabetes, and even other immunological disorders.
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Introduction
The recent epidemics of obesity and type 2 diabetes mellitus
(T2DM) in the past 20 years have stimulated researchers to
investigate the mechanisms that are responsible for the develop-
ment of these diseases. The general view is that obesity and T2DM
have a genetic background and are strongly influenced by the
environment and that insulin resistance is an early alteration in
these diseases [1–5]. In addition, studies over the past 10 years
have also shown that subclinical inflammation has an important
role in the molecular mechanism of insulin resistance in obesity
and T2DM [6–10]. During the past five years, an increasing body
of literature has suggested other components of the mechanisms of
these diseases that lie between the genetic and the environment
factors, where the gut microbiota are now considered to make an
important contribution to these mechanisms [11–16]. Then, it is
now clear that environmental factors and host genetics interact to
control the gut microbiota, which may have a role in the
development of obesity and insulin resistance [17].
Metagenomic studies demonstrated that the proportion of
Firmicutes is higher in obese animals and in humans, compared
withlean controls, and this correlates with a highernumber of genes
encoding enzymes that break down otherwise indigestible dietary
polysaccharides, with more fermentation end products and fewer
calories remaining in the faeces of obese individuals [18,19].
Another mechanism by which the microbiome may contribute to
metabolicdisordersisbytriggeringsystemicinflammation[20].The
immune system coevolves with the microbiota during postnatal life,
which allows the host and microbiota to coexist in a mutually
beneficial relationship [21,22]. In particular, the innate immune
system has emerged as a key regulator of the gut microbiota. Innate
immune recognition of microbe-associated molecular patterns is
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role for Toll-like receptors (TLRs) [23,24]. Recent findings indicate
that TLRs, which are up-regulated in the affected tissue of most
inflammatory disorders, can mediate crosstalk between the immune
systems and whole body metabolism [23]. It has been demonstrated
that TLR4, a sensor for lipopolysaccharides on Gram-negative
bacteria, is involved in the induction of proinflammatory cytokine
expression in macrophages, adipocytes, and liver [13,25]. We and
others have demonstrated that TLR4 genetically deficient mice or
micewith aninactivating mutationforthis receptoraresubstantially
protected from obesity-induced insulin resistance [26,27]. Similarly,
TLR2 genetically deficient mice are protected from high-fat-
induced insulin resistance [28,29]. On the other hand, TLR5-
deficient mice exhibit hyperphagia and develop hallmark features of
metabolic syndrome, including hyperlipidemia, hypertension,
insulinresistance,and increased adiposity [30],and thesealterations
are the consequence of alterations in the gut microbiota. It is
important to emphasize that the studies that investigated TLR4-
and TLR5-deficient mice were performed without germ-free
conditions [26,27,30], suggesting that the microbiota have an
important influence on TLR5-deficient mice phenotype, inducing
obesity and insulinresistance; however, in the TLR4-deficient mice,
themicrobiotado nothavea role in thesephenomena because these
animals are protected from diet-induced insulin resistance,
independently of germ-free conditions [26,27]. Taken together,
these findings suggest that the interaction of the innate immune
system with gut microbiota may determine the insulin sensitivity of
an animal and that TLRs may have different roles in this process.
Sincein most studies with TLR2-deficient mice the microbiota were
not investigated, we cannot predict the influence of microbiota in
the protection or in the development of insulin resistance in these
mice. It is possible that the presence of a diverse gut microbiota
could completely reverse the phenotype of an animal, inducing
insulin resistance in an animal genetically determined to have
increasedinsulinsensitivity,suchasthe TLR2KOmice.Theaimof
the present study was to investigate the influence of gut microbiota
in metabolic parameters, glucose tolerance, insulin sensitivity, and
signaling of TLR2-deficient mice.
Results
Animal Characteristics
TLR2 KO mice did not present any difference in weight gain,
compared with their controls up until 12 wk. However, after 12 wk,
TLR2 KO mice were heavier than their controls (p,0.05;
Figure 1A). No significant differences were observed with regard
tofoodintakebetweenthegroupsaftereither8or16 wk(Figure1B).
The food intake was also normalized for body weight and no
difference was observed between groups at 8 wk old
(WT=0.2260.035 g/g animal/day; TLR2 KO=0.2160.021 g/
g animal/day). However, after 16 wk, TLR2 KO mice presented
increased epididymal fat weight (Figure 1C). After 12 wk, the
amount of adipose tissue is visually increased in TLR2 KO mice
(Figure 1D). It is interesting that TLR2 KO mice at 8 wk old had
decreased glucose tolerance compared to their controls (p,0.05;
Figure 1E), but no difference was observed in fasting serum insulin
between the groups (Figure 1F). We next submitted these animals to
a hyperinsulinemic euglycemic clamp to investigate insulin
sensitivity; results showed that TLR2 KO mice presented a
significant decrease in the rate of glucose uptake under high insulin
stimulus (50% of control, p,0.05; Figure 1G), indicating a clear
situation of insulin resistance.
We next analyzed the oxygen consumption from both groups
and observed that TLR2 KO mice presented decreased oxygen
consumption (Figure 1H), suggesting decreased energy expendi-
ture when compared with their controls. However, the respiratory
exchange ratio, approximately 0.85, was similar between the
groups (Figure 1I). As the oxygen consumption was decreased in
TLR2 KO mice, we evaluated a marker of thermogenesis in the
brown adipose tissue of both groups. The expression of the
thermogenesis-inducing protein, UCP1, was significantly de-
creased in TLR2 KO mice (Figure 1J), suggesting reduced energy
expenditure in these animals, in accordance with the reduced
oxygen consumption observed.
In order to characterize the gut microbiota of TLR2 KO mice,
we pyrosequenced the 16S ribosomal RNA (rRNA) from the stools
of these animals. TLR2 KO mice presented a different gut
microbiota, compared with their controls. The major difference
concerns the proportion of Firmicutes, which was approximately
47.92% in TLR2 KO mice, while the controls presented a
proportion of 13.95%. Moreover, TLR2 KO mice presented
47.92% Bacteroidetes and 1.04% Proteobacteria, while their
controls presented approximately 42.63% and 39.53%, respec-
tively (Figure 2A,B). TLR2 KO mice presented other differences
in regards to classes and families and these results are presented in
the Supporting Information section (Figures S1 and S2).
However, it is important to notice that we have observed
different proportions of these phyla between TLR2 KO mice and
their controls in different ages of mice. From 4-wk-old to 1-y-old
mice, we observed increased proportion of Firmicutes in TLR2
KO mice compared with the controls. We have also observed a
tendency of decreasing the proportion of Bacteroidetes progres-
sively as TLR2 KO mice get older (Figures S3, S4, S5).
Molecular Mechanisms of Insulin Resistance in TLR2 KO
Mice
Next, we determined the serum concentration of IL-6 and TNF-
a in both groups of animals and observed that TLR2 KO mice
presented reduced levels of these cytokines compared with their
Author Summary
An intricate interaction between genetic and environmen-
tal factors influences the development of obesity and
diabetes. Previous studies have shown that mice lacking
an important receptor of the innate immune system, Toll-
like Receptor 2 (TLR2), are protected from insulin
resistance. Given that the innate immune system has
emerged as a key regulator of the gut microbiota, we
undertook to investigate in this study whether the gut
microbiota have a role in modulating the response to
insulin. By rearing these TLR2 mutant mice in conventional
facilities (as opposed to ‘‘germ-free’’ conditions) we figured
that they would develop an altered gut microbiota. In
contrast to previous studies, our results show that these
TLR2 mutant mice now develop a diseased phenotype
reminiscent of metabolic syndrome, including weight gain,
and end up with gut microbiota similar to that found in
obese mice and humans. These mice could be rescued by
treatment with broad-spectrum antibiotics, which deci-
mated the microbiota. Conversely, transplantation of the
gut microbiota from these mice to wild-type mice induced
weight gain and the metabolic syndrome phenotype. Our
results indicate that the gut microbiota per se can subvert
a genetically predetermined condition previously de-
scribed as being protective towards obesity and insulin
resistance into a phenotype associated with weight gain
and its complications, such as glucose intolerance and
diabetes.
TLR2, Gut Microbiota, and Insulin Resistance
PLoS Biology | www.plosbiology.org 2 December 2011 | Volume 9 | Issue 12 | e1001212Figure 1. Metabolic parameters of TLR2 knockout (TLR2
2/2) and WT mice during 16 wk. (A) Weight gain after 16 wk. (B) Food intake after
8 and 16 wk. (C) Epididymal fat pad weight after 8 and 16 wk. (D) WT and TLR22/2 mice after 20 wk. (E) Glucose tolerance test. (F) Serum insulin
concentration. (G) Glucose uptake obtained from euglycaemic hyperinsunaemic clamp. (H) Oxygen consumption and (I) respiratory exchange rate. (J)
UCP-1 expression in the brown adipose tissue. Equal protein loading in the gel was confirmed by reblotting the membrane with an anti-b-actin
antibody (J, lower panel). All evaluations were made with mice on standard chow. Data are presented as means 6 S.E.M from six to eight mice per
group from experiments that were repeated at least three times. *p,0.05 between TLR22/2 mice and their controls.
doi:10.1371/journal.pbio.1001212.g001
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tions of leptin, adiponectin, and LPS. No significant difference was
observed between the groups with regard to leptin and adiponectin
(Figure 3C,D). On the other hand, LPS serum concentration was
increased in TLR2 KO mice (Figure 3E).
As TLR2 KO mice presented increased serum LPS levels, and
this alteration was previously described in an animal model of
obesity in which there was a reduced proportion of Bifidobacterium
[31], we investigated the proportion of this group of bacteria. We
observed that TLR2 KO mice presented a decrease in
Bifidobacterium proportion compared with WT (Figure 3F).
In order to unravel the mechanism by which the insulin
resistance occurs in the TLR2 KO mice, we studied important
pathways involved in this phenomenon: phosphorylation of JNK,
activation of ER stress, serine phosphorylation of the insulin
receptor substrate (IRS)-1, and expression of IkB-a, which is
involved in the inhibition of the IKK/NFkB pathway activation.
TLR2 KO mice presented increased phosphorylation of JNK in
muscle, liver, and adipose tissue compared with controls
(Figure 4A–C). Since the activation of ER stress leads to the
phosphorylation of JNK, the increased phosphorylation of this
protein in TLR2 KO mice could be due to this event. In fact, the
Figure 2. TLR2 KO mice exhibit taxonomical alterations in gut microbiota. Untreated WT (A) and TLR2 knockout (TLR22/2) mice (B) stools
were analyzed via 16S rRNA analysis. Data are presented from six to eight mice per group from experiments that were repeated at least three times.
All evaluations were made with mice on standard chow.
doi:10.1371/journal.pbio.1001212.g002
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tissue of the KO mice, suggesting increased ER stress activation at
least in these two tissues (Figure 4D–F).
Next, we studied the inhibitory serine phosphorylation of IRS-1 in
muscle, liver, and adipose tissue of TLR2 KO mice and observed that
this phosphorylation was increased, compared with the controls,
suggesting impairment of insulin signaling (Figure 4G–I). Since
increased serum concentration of LPS, a TLR4 ligand, was observed
in TLR2 KO mice, we investigated the activation of TLR4 in the
muscle, liver, and adipose tissue of these mice. An increased activation
of this receptor was observed in all tissues studied (Figure 4J–L),
suggesting that, in the absence of TLR2, a compensatory action may
lead to increased activation of TLR4,w h i chm a ya l s oco n t ri b ut et ot h e
development of insulin resistance in TLR2 KO mice.
Then, we studied the activation of IKK/NFkB pathway,
indirectly, by the expression of IkB-a. Curiously, the expression
of IkB-a was increased in the muscle, liver, and white adipose
tissue of TLR2 KO mice, compared with controls, suggesting a
decreased activation of IKK/NFkB pathway (Figure 4M–O). In
order to confirm this result, we studied the activation of NFkB and
observed that this was decreased in all tissues studied from TLR2
KO mice (Figure 4P–R).
Figure 3. Measurements of cytokines, adipokines, and LPS. Serum concentration of IL-6 (A), TNF-a (B), adiponectin (C), leptin (D), and LPS (E).
Proportion of Bifidobacterium was obtained by 16S rRNA analysis of stools (F). Data are presented as means 6 S.E.M from six to eight mice per group
from experiments that were repeated at least three times. * p,0.05 between TLR2 KO mice and their controls; all evaluations were made with mice
on standard chow.
doi:10.1371/journal.pbio.1001212.g003
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receptor (IR) (Figure S6A–C) and of the insulin receptor substrate
(IRS)-1 (Figure 5A–C), as well as the insulin-induced serine
phosphorylation of AKT, was decreased in the muscle, liver, and
adipose tissue of TLR2 KO mice (Figure 5D–F), compared with
their controls, suggesting reduced insulin signaling in these tissues.
Other proteins that are important in the modulation of insulin
action were also investigated. Our data showed that the
phosphorylation of AMPK (Figure S6D–F) and the expression of
PGC-1a (Figure S6G–I) were similar between controls and TLR2
KO mice in the three tissues investigated.
As an increased phosphorylation of JNK was observed in TLR2
KO mice, we prevented the activation of this protein with a
pharmacological inhibitor, SP600125, by treating mice with daily
i.p. injections for 5 d. Subsequently, we observed an increased
glucose uptake in these animals, suggesting that the activation of
JNK is indeed relevant to the development of insulin resistance
(Figure 6A). We also observed increased insulin-induced serine
Figure 5. TLR2 knockout (TLR22/2) mice present decreased insulin signaling. Tyrosine 941 phosphorylation of the insulin receptor
substrate (IRS)-1 in muscle (A), liver (B), and WAT (C). Serine phosphorylation of AKT in muscle (D), liver (E), and WAT (F). IRS-1 and AKT protein
expression in muscle, liver, and white adipose tissue (A–F, lower panels). Equal protein loading in the gel was confirmed by reblotting the membrane
with an anti-b-actin antibody (lower panels). All evaluations were made with mice on standard chow. Data are presented as means 6 S.E.M from six
to eight mice per group from experiments that were repeated at least three times. *p,0.05 between WT with and without insulin stimulus; ** p,0.05
between TLR22/2 mice and their controls with insulin stimulus.
doi:10.1371/journal.pbio.1001212.g005
Figure 4. Evaluation of pathways involved in the impairment of insulin signaling. Phosphorylation of JNK in muscle (A), liver (B), and white
adipose tissue (WAT) (C). Phosphorylation of PERK in muscle (D), liver (E), and WAT (F). Serine 307 phosphorylation of IRS-1 from muscle (G), liver (H),
and WAT (I). Activation of TLR4 (studied by the immunoprecipitation of MyD88 and blotting with TLR4) in muscle (J), liver (K), and WAT (L). JNK, PERK,
and IRS-1 protein expression in muscle, liver, and white adipose tissue (A–I, lower panels). Expression of IkB-a in muscle (M), liver (N), and WAT (O).
Equal protein loading in the gel was confirmed by reblotting the membrane with an anti-b-actin antibody (M–O, lower panels). NFkB activation in
muscle (P), liver (Q), and WAT (R). All evaluations were made with mice on standard chow. Data are presented as means 6 S.E.M from six to eight
mice per group from experiments that were repeated at least three times. * p,0.05 between TLR22/2 mice and their controls.
doi:10.1371/journal.pbio.1001212.g004
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white adipose tissue (unpublished data) of TLR2 KO mice after
this treatment, suggesting increased insulin signaling, as well,
associated with a reduction in JNK phosphorylation in the liver of
TLR2 KO mice (Figure 6D).
An increased activation of ER stress leads to the activation of
JNK [32,33]. Therefore, we studied whether preventing the
activation of this phenomenon could improve the insulin sensitivity
and signaling. For this purpose, we treated mice with a
pharmacological inhibitor of ER stress, 4-phenyl butyric acid
(PBA), using i.p. daily injections for 10 d. This treatment was
found to lead to an increased glucose uptake in TLR2 KO mice
(Figure 6A) and increased insulin-induced serine phosphorylation
of AKT in the liver (Figure 6B), muscle, and white adipose tissue
(unpublished data), suggesting an improvement in the insulin
signaling as well. After this treatment, we also investigated the
phosphorylation of JNK and observed a reduction in the liver
(Figure 6D) of TLR2 KO mice. Results suggest that both the
activation of ER stress and the activation of JNK are important
contributors to the development of the phenotype observed in
TLR2 KO mice.
Since TLR4 was more activated in the tissues of TLR2 KO
mice, possibly constituting one of the mechanisms responsible for
the development of insulin resistance, we inhibited its expression
using a TLR4 antisense oligonucleotide (ASO; with two daily i.p.
injections) for 5 d. After TLR4 ASO treatment, TLR2 KO mice
were found to present a significantly increased glucose uptake
during the euglycemic hyperinsulinemic clamp compared with
their controls (Figure 6A). The insulin signaling was also increased,
with increased insulin-induced serine phosphorylation of AKT in
the liver (Figure 6C), muscle, and white adipose tissue (unpub-
lished data) of TLR2 KO mice. After this treatment, decreased
phosphorylation of JNK was observed in the liver (Figure 6D) of
TLR2 KO mice.
Using another method to inhibit TLR4 signaling, a pharma-
cological inhibitor of TLR4, TAK-242, was administered daily by
gavage during 5 d and confirmed the results seen with the TLR4
ASO treatment. The insulin sensitivity was increased in TLR2
KO-treated animals (Figure 6A), and the insulin-induced serine
phosphorylation of AKT was also increased in the liver (Figure 6C)
of these animals, suggesting an improvement in insulin signaling.
The phosphorylation of JNK was decreased in the liver (Figure 6D)
of TLR2 KO treated mice.
As the serum LPS levels were increased in TLR2 KO mice, and
the changes in microbiota may not account for this increase, we
tested whether the LPS absorption was also increased in these
animals. For this purpose, we administered LPS orally to TLR2
KO mice and wild type mice and determined the circulating LPS
levels 1 h later. We observed that all animals presented increased
serum LPS concentration after the LPS administration. However,
TLR2 KO mice presented a higher increase in serum LPS
concentration after the treatment, compared with the wild type
mice (Figure 6E). As this result suggested that TLR2 KO mice
presented increased gut permeability, we investigated the expres-
sion of an important tight-junction protein of the ileum of these
mice, zonula occludens (ZO)-1, and observed that it was indeed
decreased, compared with the control mice (Figure 6F). Reduction
of ZO-1 expression in TLR2 KO mice was also observed in other
parts of the small intestine and in the colon (unpublished data).
Previous data showed that TLR2 KO mice have a decreased
number of regulatory T cells in the circulation compared with
control mice [34]. This can have a role in the modulation of
intestinal barrier and also in insulin resistance. We next
investigated the frequency of Foxp3+ CD4+ T regulatory cells in
mesenteric adipose tissue. We observed that the frequency of these
cells was decreased in TLR2 KO mice (Figure 6H), compared
with the wild type mice (Figure 6G).
Treatment of TLR2 KO Mice with Antibiotics Changes the
Composition of Their Gut Microbiota and Improves
Insulin Sensitivity
As the gut microbiota from TLR2 KO mice was shown to differ
from that of controls, we treated both groups with a mixture of
antibiotics (ampicillin, neomycin, and metronidazole) in their
drinking water for 20 d. Moreover, we characterized the gut
microbiota of TLR2 KO mice using culture-based microbial
analysis of cecal contents after the antibiotics treatment and the
results showed that aerobic bacteria were almost suppressed, while
anaerobic bacteria decreased its abundance to 40% compared to
the control group (Figure S7A).
After the treatment with the mixture of antibiotics, we also
observed changes in the relative abundance of three phyla of
bacteria. The abundance of Bacteroidetes was reduced from
47.92% to 19.78% and Firmicutes abundance decreased from
47.92% to 11.76% in the TLR2 KO mice, while Proteobacteria
abundance increased from 1.04% to 67.38% in these mice (Figure
S7B,C). TLR2 KO treated mice presented other differences in
regards to classes and families and these results are presented in
the Supporting Information section (Figures S8 and S9). When
TLR2 KO mice were treated with metronidazole, neomycin, and
ampicillin individually, and not as an antibiotics mixture, we
observed that ampicillin was the most effective one to exterminate
more bacteria diversity. When treated with metronidazole, TLR2
KO mice presented 46.51% of Proteobacteria, 10.69% of
Firmicutes, and 42.32% of Bacteroidetes. When treated with
neomycin, TLR2 KO mice presented 44.18% of Firmicutes and
55.81% of Bacteroidetes. When treated with ampicillin, almost
100% of the sequenced bacteria left corresponded to Proteobac-
teria (Figure S10A–C). Since the treatment with ampicillin or
metronidazole normalized glucose tolerance in TLR2 KO mice,
Figure 6. Insulin sensitivity and signaling after treatment with selective inhibitors. Glucose uptake obtained by the euglycaemic
hyperinsulinaemic clamp from TLR22/2 mice treated or not with the drugs: SP600125 (SP), JNK inhibitor; 4-phenil butyric acid (PBA), endoplasmic
reticulum stress inhibitor; TLR4 antisense oligonucleotide (ASO); (A) TAK-242, inhibitor of TLR4. (B) Serine phosphorylation of AKT after the treatment
with SP600125 and PBA. (C) Serine phosphorylation of AKT after the treatment with TLR4 ASO and TAK-242. (D) Phosphorylation of JNK after the
treatment with the drugs mentioned. Fasted TLR2 knockout mice and WT mice were gavaged by LPS (1.08, 10
28 g) diluted in water (100 mL) or without
LPS. (E)Bloodwascollected from thecava vein 60 min aftergavage andserum LPS was determined.(F)Zonulaoccludens(ZO)-1expression intheileum.
(G) Frequency of CD4+Foxp3+ regulatory T cells in WT mice. (H) Frequency of CD4+Foxp3+ regulatory T cells in TLR22/2 mice. All evaluations were
made with mice on standard chow. Data are presented as means 6 S.E.M from six to eight mice pergroup from experiments thatwere repeated at least
three times. * p,0.05 between WT mice with or without insulin stimulus; ** p,0.05 between WT and TLR22/2 mice with insulin stimulus ; $ p,0.05
between TLR22/2micewithinsulin stimulus,treatedornotwithSP; # p,0.05betweenTLR22/2micewithinsulin stimulus, treatedornot withPBA;1
p,0.05 between TLR22/2 mice with insulin stimulus, treated or not with ASO; & p,0.05 between TLR22/2 mice with insulin stimulus, treated or not
with TAK-242;
a p,0.05 between WT mice with or without LPS stimulus; u p,0.05 between WT and TLR22/2 mice with LPS stimulus.
doi:10.1371/journal.pbio.1001212.g006
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PLoS Biology | www.plosbiology.org 9 December 2011 | Volume 9 | Issue 12 | e1001212Figure 7. Alterations in the metabolic parameters and in insulin signaling and sensitivity after treatment with antibiotics. (A)
Epididymal fat pad weight. (B) Visceral adipose tissue weight. (C) Glucose tolerance test. (D) Oxygen consumption. (E) Glucose uptake obtained by the
euglycaemic hyperinsulinaemic clamp. (F) UCP-1 expression in the brown adipose tissue. (G) Serine phosphorylation of AKT after the treatment with
TLR2, Gut Microbiota, and Insulin Resistance
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mice (unpublished data), we can speculate that the changes in
microbiota induced by ampicillin or metronidazole are more
relevant than the changes induced by neomycin, although no
specific genera of bacteria can be implicated in this response.
However, in accordance with previous data on obese mice, the
decrease in the proportion of the phylum Firmicutes, as observed
in the groups that received ampicillin or metronidazole, correlates
with the improvement in glucose tolerance.
TLR2 KO mice presented decreased epididymal fat pad and
visceral adipose tissue weight after the treatment with antibiotics
compared with non-treated TLR2 KO, while no difference was
observed in the treated and non-treated control animals
(Figure 7A,B). TLR2 KO mice also presented increased glucose
tolerance (Figure 7C) and increased oxygen consumption
(Figure 7D) after the treatment compared with non-treated
TLR2 KO mice, but no significant difference was observed
between treated and non-treated control mice. With regard to
insulin sensitivity and signaling, we observed an improvement in
insulin-induced glucose uptake, using the euglycemic hyperinsu-
linemic clamp, in TLR2 KO mice after antibiotics treatment
(Figure 7E), with no difference in the treated and non-treated
control mice. After the treatment, we also observed an increase in
the UCP-1 expression in the brown adipose tissue of TLR2 KO
mice, supporting the increased oxygen consumption observed in
this condition (Figure 7F). We also observed an increased insulin-
induced serine phosphorylation of AKT in the liver (Figure 7G),
muscle, and white adipose tissue (unpublished data) of TLR2 KO
mice after the treatment. Moreover, there was a decreased
phosphorylation of JNK in the liver (Figure 7H), muscle, and white
adipose tissue (unpublished data) of the knockout mice after the
treatment. The antibiotics treatment also led to an increased
expression of ZO-1 in TLR2 KO mice, with no difference in the
treated and non-treated control mice (Figure 7I). These data
suggest that, in TLR2 KO mice, the reduction in their gut
microbiota associated with qualitative changes in composition,
induced by antibiotics, was able to reverse the insulin resistance of
these animals.
Effect of Microbiota Transplantation from TLR2 KO Mice
to Control Mice on Weight Gain and Insulin Sensitivity
In order to investigate whether the gut microbiota was
responsible for triggering all the alterations seen in TLR2 KO
mice, we transplanted the cecal microbiota from TKR2 KO mice
and from WT mice in 4-wk-old-Bacillus-associated WT mice,
which contain few species of the genus Bacillus, without any other
genera, as obtained by 16S rRNA pyrosequencing, in the
following proportion: Bacillus simplex (0.68%), Bacillus sp (1.1%),
Bacillus sp Kaza-34 (6.28%), and uncultured Bacillus (91.96%).
There was a non-significant increase in the epididymal adipose
tissue fat pad weight, in the total body weight gain, in the fasting
blood glucose, and in the oxygen consumption in Bacillus-
associated mice transplanted with WT microbiota
(Figure 8A,C,D,G). However, in Bacillus-associated mice trans-
planted with TLR2 KO microbiota, we observed a marked
increase in the epididymal fat pad and visceral adipose tissue
weight (Figure 8A,B); in the body weight gain (Figure 8C), with a
trend towards increased fasting blood glucose (Figure 8D), as well
as a decrease in the glucose tolerance (Figure 8E,F); in the oxygen
consumption (Figure 8G); and in the insulin sensitivity, obtained
by euglycemic hyperinsulinemic clamp, compared with those
transplanted with WT microbiota (Figure 8H) 8 wk after the
transplantation (p,0.05). Bacillus-associated mice transplanted
with WT microbiota also presented decreased insulin sensitivity
compared with the non-transplanted mice (p,0.05). Bacillus-
associated WT mice transplanted with TLR2 KO or with WT
microbiota also showed decreased expression of UCP-1 in the
brown adipose tissue compared with the non-transplanted mice.
Bacillus-associated mice transplanted with TLR2 KO microbiota
showed marked decrease in UCP-1 expression compared with
those transplanted with WT microbiota (Figure 8I). Moreover,
these animals had decreased insulin signaling, as seen by the
reduction in serine phosphorylation of AKT in liver, compared to
mice transplanted with WT microbiota (Figure 8J). In the mice
transplanted with TLR2 KO microbiota, there was increased
phosphorylation of JNK in liver (Figure 8K), muscle, and white
adipose tissue (unpublished data) compared with the mice
transplanted with WT microbiota. The experiments described
above had also been performed in few germ-free mice, but with
very similar results (unpublished data).
Eight weeks after the transplantation, the expression of ZO-1
was evaluated in the 12-wk-old mice. We observed that it was
decreased in mice transplanted with TLR2 KO microbiota
compared to those transplanted with WT microbiota (Figure 8L).
The same data were observed in other parts of the small intestine
and in the colon (unpublished data).
We also investigated the frequency of CD4+Foxp3+ regulatory
T cells in these animals and observed that they were decreased in
mesenteric adipose tissue in mice transplanted with TLR2 KO
microbiota (Figure 8O) compared with the mice transplanted with
WT microbiota (Figure 8N) and non-transplanted Bacillus-
associated mice (Figure 8M).
In summary, as expected, the transplantation of a wild-type
microbiota in Bacillus-associated mice resulted in a moderate
increase in adipose visceral fat and in a mild decrease in glucose
tolerance. However, the effect of the transplantation of TLR2 KO
microbiota in Bacillus-associated mice induced marked changes,
and clearly indicates deleterious effects of this TLR2 KO
microbiota on body weight and glucose metabolism.
Effect of High-Fat Diet (HFD) on Weight Gain and Insulin
Sensitivity in TLR2 KO Mice
Next, we investigated the effect of high-fat diet (HFD) on
metabolic parameters of TLR2 KO mice. The results showed that
at 8 wk old TLR2 KO mice on a HFD presented increased body
weight (Figure 9A), similar food intake (WT=7.3 g per day,
TLR2 KO=6.1 g per day; WT=0.2560.055 g/g animal/day;
TLR2 KO=0.1960.046 g/g animal/day) (Figure 9B), increased
epididymal fat weight (Figure 9C), reduced glucose tolerance
(Figure 9D), increased fasting serum insulin (Figure 9E), and
reduced glucose uptake (Figure 9F) compared to the controls. The
oxygen consumption of both groups was compared and TLR2
KO mice were seen to present decreased oxygen consumption
(Figure 9G), suggesting decreased energy expenditure compared to
AB. (H) Phosphorylation of JNK after the treatment with AB. (I) Zonula occludens (ZO)-1 expression in the ileum. Equal protein loading in the gel was
confirmed by reblotting the membrane with an anti-b-actin antibody (lower panels). Data are presented as means 6 S.E.M from six to eight mice per
group, from experiments that were repeated at least three times. All evaluations were made with mice on standard chow. # p,0.05 between WT
mice with or without insulin stimulus; * p,0.05 between WT and TLR22/2 mice with insulin stimulus; ** p,0.05 between TLR22/2 and TLR22/2
treated with AB, with insulin stimulus.
doi:10.1371/journal.pbio.1001212.g007
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Visceral adipose tissue weight. (C) Weight gain of transplanted mice. (D) Serum glucose. (E) Glucose tolerance test. (F) Incremental area under curva
(IAUC) obtained from the glucose tolerance test. (G) Oxygen consumption. (H) Glucose uptake obtained by the euglycaemic hyperinsulinaemic
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in both groups, being around 0.75 (Figure 9H). In accordance with
the reduced oxygen consumption observed, the expression of
UCP1 was significantly decreased in TLR2 KO mice (Figure 9I).
Similarly, insulin signaling was reduced in TLR2 KO mice fed on
the HFD. The insulin-induced serine phosphorylation of AKT was
reduced in the muscle, liver, and white adipose tissue of TLR2 KO
mice, compared with controls (Figure 10A–C). Moreover, the
phosphorylation of JNK was increased in all tissues studied of the
TLR2 KO mice (Figure 10D–F), while the expression of IkB-a
was increased (Figure 10G–I), suggesting that the IKK/NFkB
pathway is decreased in TLR2 KO mice on a HFD, as observed
for mice on a standard chow. These results suggest that the
metabolic phenotype of the TLR2 KO mice characterized by
insulin resistance is aggravated by HFD, which leads to the
development of diabetes, as demonstrated by fasting blood glucose
and glucose tolerance tests.
Discussion
It is now considered that environmental factors and host
genetics interact to control the acquisition and stability of gut
microbiota. In turn, environment, host genetics, and microbiota
interact to maintain the homeostasis of gut, weight control, and
insulin sensitivity [17]. Clearly, the modification of one or more of
these three components may trigger the development of insulin
resistance and obesity. The results of the present study
demonstrated that TLR2 KO mice in conventionalized conditions
in our breeding center have insulin resistance and glucose
intolerance associated with alterations in the composition of the
gut microbiota, which displayed an increase in the relative
abundance of Firmicutes and Bacteroidetes and decreased relative
abundance of Proteobacteria, compared to their controls. The
insulin resistance of TLR2 KO mice was accompanied by a down-
modulation of insulin-induced insulin signaling in the liver,
muscle, and adipose tissue, associated with an increase in
endoplasmic reticulum stress. These metabolic alterations were
characterized in 8-wk-old TLR2 KO mice, when they had similar
body weights to the control animals. As demonstrated in other
animal models [35,36], this insulin resistance precedes the
development of obesity, and an augmentation in body weight
compared to controls is observed after the 12th wk of age.
However, previous studies [28,37] have reported that TLR2
KO mice present decreased body weight and adiposity, are
protected against insulin resistance, and gain less weight on a HFD
than control mice and are also protected against related
comorbidities [38,39]. We believe that the main difference
between these studies and our study may be related to gut
microbiota. It should be taken into consideration that although the
animals have the same genetic deficiency they were bred in
different rooms and fed with food from different sources, which
can certainly have a role in the establishment and maintenance of
gut microbiota. Although in most of the previous studies the gut
microbiota was not investigated, we can suggest that TLR2
deficiency associated with different environmental conditions can
induce different phenotypes, probably induced by different
microbiotas. Kellermayer et al. have shown that the proportion
of Firmicutes found in TLR2 KO mice was lower than in WT,
while the proportion of Bacteroidetes was increased [40]. In our
study, we show that TLR2 KO mice present the opposite, with
increased proportion of Firmicutes and decreased proportion of
Bacteroidetes, compared with the WT. This way, it is possible that
in the other published studies the proportions of this phyla might
be different, compared with the proportions we have found, which
might influence differently the phenotype observed. These results
reinforce the importance of environment and of the innate
immune system as key regulators of gut microbiota and suggest
that a genetic condition, which by itself can prevent insulin
resistance in some conditions, can also overcome the protective
effect on insulin resistance in other environmental conditions
inducing more weight gain, probably due to differences in the
microbiota. In addition, these findings may help explain
differences in the metabolic behavior of the same animal, when
analyzed in distinct environments, and can contribute to
explaining differences in metabolic behavior between animals
with the same background or with the same genetic alteration.
The mechanisms by which the TLR2 KO mice presented
insulin resistance and, later, obesity were also investigated. The gut
microbiota of the TLR2 KO animal have some similarities to
those found in obese animals and humans, with an increase in
Firmicutes [41,42]. This type of microbiota is usually associated
with an increased capacity for energy harvesting from the diet
[19]. This might contribute to explaining the obesity observed, but
does not explain why these animals are clearly insulin resistant
many weeks before they start to gain more weight than their
controls. In addition, it was demonstrated that germ-free (that gain
less weight on HFD) and conventionalized mice have similar
energy contents in their feces, suggesting that other mechanisms
may have an important role in gut microbiota-induced insulin
resistance and obesity [43]. Additionally some studies suggest that
the gut microbiota can contribute to obesity by inducing a
reduction in fat oxidation and an increase in fat storage [43],
associated with a relative reduction in the expression of PGC1
alpha and in AMPK phosphorylation. This mechanism is less
probable in our animal model, because the RQ of TLR2 KO mice
was identical to that of control mice, showing that they were
oxidizing fat in the same proportion of controls, and also the tissue
levels of PGC1alpha and also the phosphorylation of AMPK were
similar in liver and muscle of controls and TLR2 KO mice.
Another possible mechanism that could induce insulin resis-
tance in obesity is the increased level of LPS, which is observed in
HFD mice [11,44]. Notably, although TLR2 KO mice were fed
on standard rodent chow, they presented higher circulating levels
of LPS. Since the microbiota of these mice had a predominance of
Firmicutes, which are gram-positive, and do not have LPS in the
outer membrane, the increase of LPS circulating levels is certainly
not the consequence of a microbiota that produces more LPS.
However, the microbiota observed in obesity and also in TLR2
clamp. (I) UCP-1 expression in the brown adipose tissue. (J) Serine phosphorylation of AKT after the treatment with AB. (K) Phosphorylation of JNK
after the treatment with AB. AKT and JNK protein expression in the liver of transplanted mice (J, K, lower panels). (L) Zonula occludens (ZO)-1
expression in the ileum. (M) Frequency of CD4+Foxp3+ regulatory T cells in Bacillus-associated mice. (N) Frequency of CD4+Foxp3+ regulatory T cells
in Bacillus-associated mice transplanted with WT microbiota. (O) Frequency of CD4+Foxp3+ regulatory T cells in Bacillus-associated mice transplanted
with TLR22/2 microbiota. Equal protein loading in the gel was confirmed by reblotting the membrane with an anti-b-actin antibody (lower panels).
Data are presented as means 6 S.E.M from six to eight mice per group from experiments that were repeated at least three times. All evaluations were
made with mice on standard chow. * p,0.05 between Bacillus-associated mice transplanted with TLR22/2 microbiota (MA+TLR22/2) and those
transplanted with WT microbiota (MA+WT); ** p,0.05 between Bacillus-associated mice transplanted with WT microbiota (MA+WT) and Bacillus-
associated mice (MA); # p,0.05 between Bacillus-associated mice with or without insulin stimulus.
doi:10.1371/journal.pbio.1001212.g008
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PLoS Biology | www.plosbiology.org 13 December 2011 | Volume 9 | Issue 12 | e1001212Figure 9. Metabolic parameters of TLR2 KO (TLR22/2) mice fed a high-fat diet. (A) Weight gain after 10 wk of high-fat diet (HFD). (B) Food
intake. (C) Epididymal fat pad weight. (D) Glucose tolerance test. (E) Serum insulin concentration. (F) Glucose uptake obtained from the euglycaemic
hyperinsulinaemic clamp. (G) Oxygen consumption and (H) respiratory exchange rate. (I) UCP-1 expression in the brown adipose tissue. Data are
presented as means 6 S.E.M from six to eight mice per group from experiments that were repeated at least three times. All evaluations were made
with mice on standard chow. * p,0.05 between TLR22/2 mice and their controls.
doi:10.1371/journal.pbio.1001212.g009
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47]. Importantly, as observed in obese animals, which present a
significant reduction in Bifidobacteria [48,49], in the microbiota of
lean TLR2 KO mice this genera was reduced compared with the
controls. In this regard, the supplementation of Bifidobacteria has
been linked to an improvement in the gut barrier function and to
reduced levels of LPS [31,50,51]. In order to prove that the
increased circulating LPS levels of TLR2 KO mice were related to
gut permeability, we administered LPS orally to these mice and
observed that, in addition to higher basal LPS levels, these animals
also showed a higher peak of LPS 1 h after oral gavage of this
lipopolysaccharide.
Previous data showed that TLR2 regulates tight junction (TJ)-
associated intestinal epithelial barrier integrity and that TLR2
deficiency predisposes to alterations of TJ-modulated barrier
function leading to perpetuation of mucosal inflammation [52,53].
Figure 10. Insulin signaling is impaired in TLR2 knockout (TLR22/2) mice fed on a high-fat diet. Phosphorylation of AKT in muscle (A),
liver (B), and white adipose tissue (WAT) (C). AKT protein expression in muscle, liver, and WAT (A–C, lower panels). Phosphorylation of JNK in muscle
(D), liver (E), and WAT (F). JNK protein expression in muscle, liver, and WAT (D–F, lower panels). IkB-a expression in muscle (G), liver (H), and WAT (I).
Equal protein loading in the gel was confirmed by reblotting the membrane with an anti-b-actin antibody (lower panels). All evaluations were made
with mice on standard chow. Data are presented as means 6 S.E.M from six to eight mice per group from experiments that were repeated at least
three times. * p,0.05 between TLR22/2 mice and their controls, with insulin stimulus; ** p,0.05 between WT with and without insulin stimulus.
doi:10.1371/journal.pbio.1001212.g010
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mice, there is a reduction in ZO-1 in the small intestine and in the
colon, reinforcing that there are alterations in epithelial integrity
and gut permeability in these mice. Taken together, these results
suggest that the interactions between the predisposition of TLR2
KO mice to alterations in barrier function and the microbiota may
have an important role in the increased circulating LPS levels
observed in these mice.
In accordance with alterations in gut permeability, Kellermayer
et al. recently investigated the epigenomic and metagenomic
consequences of Tlr2 deficiency in the colonic mucosa of mice in
order to understand the biological pathways that shape the
interface between the gut microbiota and the mammalian host.
The results showed epigenomic and transcriptomic modifications
associated with alterations in mucosal microbial composition and
the abundance of many bacterial species were found to differ
between WT and TLR2 KO animals. The expression of genes
involved in the immune system was modified in the colonic
mucosa of TLR2 KO mice, which correlated with DNA
methylation changes. This pioneer study demonstrates that
significant microbiota shifts associate with epithelial epigenetic
changes influenced by the host genome [54].
In order to confirm that gut microbiota was inducing insulin
resistance in TLR2 KO mice, we treated these mice with
antibiotics for 15 d and showed that this treatment dramatically
reduced the gut microbiota and also changed its composition. In
parallel, there was an improvement in insulin action, characterized
by an increased glucose infusion rate during the glucose clamp,
and also an improvement in insulin signaling in the liver, muscle,
and adipose tissue. In the TLR2 KO mice treated with antibiotics,
we also observed a marked reduction in LPS levels. When we
performed gut microbiota transplantation of TLR2 KO mice to
Bacillus-associated WT mice, which are colonized only by the
genus Bacillus and are capable of receiving a different microbiota
from other mice, the complex composition of the transferred
organism was preserved. The transplanted TLR2 KO mice
microbiota conferred more weight gain, glucose intolerance, and
reduced insulin sensitivity and signaling, associated with increased
LPS circulating levels. These data reinforce the hypothesis that the
TLR2 KO mice microbiota are able to induce changes in the gut
permeability, in turn increasing serum LPS levels, associated with
insulin resistance.
The increase in LPS may induce insulin resistance by
counteracting insulin signaling, as previously demonstrated
[11,55,56]. However, the insulin resistance observed in TLR2
KO mice has unique characteristics. There was activation of
TLR4 in the liver, muscle, and adipose tissue, associated with ER
stress and JNK activation, but no activation of the IKKb-IkB-
NFkB pathway. It was previously described that there is
cooperation between TLR4 and TLR2 signaling. This coopera-
tion is evident when LPS is injected in TLR2 KO mice. After the
first bolus of LPS, TLR2 KO mice show a robust signal for genes
encoding innate immune proteins in the brain. However, the
second LPS infusion failed to trigger TNFalpha in TLR2 KO
mice. These results indicate that TLR2 is involved in the second
wave of TNFalpha expression after LPS and that there is an
elegant cooperation between TLR2 and TLR4 [57]. Our results
extended these data by showing that the chronic elevation in LPS
levels in TLR2 KO mice was not able to increase IKK/IkB/NF-
kB pathway and TNFalpha and IL-6 production, but induced an
increase in JNK activation in liver, muscle, and adipose tissue of
these mice. These data suggest that chronic activation of TLR4 by
low doses of LPS is sufficient to increase JNK activation, but the
activation of IKK/IkB/NF-kB pathway may also depend on the
cooperation between TLR2 and TLR4.
The absence of activation of the NFkB pathway and the
reduced levels of TNFa and IL-6 make the insulin resistance of
TLR2 KO mice different from that observed in DIO mice or in
ob/ob mice. We can, thus, suggest that the increase in LPS
circulating levels caused activation of TLR4, induced ER stress
and JNK activation accompanied by increased IRS-1 serine 307
phosphorylation in the liver, muscle, and adipose tissue, leading to
a reduction in insulin sensitivity and signaling and conferring the
phenotype observed in the TLR2 KO mice. Phosphorylation of
IRS-1 on serine residues interferes with the subsequent insulin-
stimulated tyrosine phosphorylation of IRS-1 by IR [58] and IRS-
1 can also mediate inhibition of the insulin receptor tyrosine kinase
activity [55], and also with downstream signaling as Akt
phosphorylation. This insulin signaling pathway is crucial for the
metabolic effects of insulin on glucose metabolism [59]. The
pharmacological or genetic blockage of TLR4, of ER stress, or of
JNK improved action and signaling of insulin in TLR2 KO mice,
confirming that this sequence of events has an important role in
the insulin resistance of these animals.
Regulatory T cells, a small subset of T lymphocytes, are thought
to be one of the body’s most important defenses against
inappropriate immune responses [60,61] and can influence the
activities of cells of the innate immune system [62–64]. Previous
data showed that regulatory T cells were highly enriched in the
abdominal fat of control mice and reduced at this site in animal
models of obesity. This reduction in obesity of regulatory T cells
influenced the inflammatory state of adipose tissue and certainly
contributes to insulin resistance. Our data showing that in TLR2
KO mice there is a reduction in regulatory T cell in visceral
adipose tissue may suggest that this modulation may also
contribute to the insulin resistance observed in these animals.
The development of obesity and insulin resistance in humans is
thought to be promoted by a HFD. Feeding TLR2 KO mice with
a HFD for 8 wk caused a marked increase in body weight and in
fasting plasma glucose, with levels of over 400 mg/dl at 2 h during
the glucose tolerance test, demonstrating that these animals
developed not only a more severe form of insulin resistance but
also diabetes. The alterations in insulin signaling in tissues also
showed a marked down-regulation, in parallel with a higher
activation of JNK compared to their controls on HFD.
Interestingly, the absence of activation of the IKKb-IkB-NFkB
pathway, described in TLR2 KO mice on standard rodent chow,
was also observed when these mice were on HFD. These results
demonstrate that the insulin resistance, and later the increase in
body weight observed in TLR2 KO mice, is exacerbated by HFD.
A recent report demonstrated that genetically deficient TLR5
mice exhibit hyperphagia, hyperlipidemia, insulin resistance, and
increased adiposity [30]. These metabolic alterations correlated
with changes in the composition of the gut microbiota. Our model,
although showing similar features, presented different aspects that
may suggest that different mechanisms may be operating in TLR5
or TLR2 KO mice. First, TLR2 KO mice did not present
hyperphagia, and the difference in body weight starts only when
these animals are 16 wk old. In the TLR5 KO mice, the insulin
resistance is not dependent on TLR4, but in TLR2 KO mice there
is an increase in circulating LPS and activation of TLR4. It is
possible that these differences not only represent differences in
genetic defects but also differences in gut microbiota between these
mice.
In conclusion, we may suggest that the loss of TLR2 in
conventionalized mice results in a reminiscent phenotype of
metabolic syndrome, characterized by a clear difference in the gut
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mation associated with ER stress, glucose intolerance, and later
obesity, which is reproduced in WT by microbiota transplantation
and can be reversed using antibiotics. Our results emphasize the
role of microbiota in the complex network of molecular and
cellular interactions that bridge genotype to phenotype and have
potential implications for a wide array of common human




Human recombinant insulin was from Eli Lilly (Indianapolis,
Indiana, USA). Reagents for SDS-PAGE and immunoblotting
were from Bio-Rad. HEPES, phenylmethylsulfonyl fluoride,
aprotinin, dithiothreitol, Triton X-100, Tween 20, glycerol, and
bovine serum albumin (fraction V) were from Sigma. Protein A-
Sepharose 6MB was from GE Healthcare, and nitrocellulose
paper (BA85, 0.2 mm) was from Amersham Biosciences. The
reagents for the chemiluminescence labeling of proteins in blots
were from Amersham Biosciences. Sense and antisense oligonu-
cleotides specific for TLR4 (sense, 59-C TGA AAA AGC ATT
CCC ACC T-39 and antisense, 59-A GGT GGG AAT GCT TTT
TCA G-39) were produced by Invitrogen Corp. (Carlsbad, CA).
Antibodies against b-actin (mouse monoclonal, sc-8432), TLR4
(rabbit polyclonal, sc-30002), phospho [Ser307]-IRS-1 (rabbit
polyclonal, sc-33956), phospho [Tyr941] (goat polyclonal, sc-
17199), IRS-1 (rabbit polyclonal, sc-559), phospho [Ser 473]-AKT
(rabbit polyclonal, sc-33437), AKT1 (goat polyclonal, sc-1618),
phospho [Thr 981]-PERK (rabbit polyclonal, sc-32577), PERK
(goat polyclonal, sc-9477), phospho-JNK (mouse monoclonal, sc-
6254), JNK1 (mouse monoclonal, sc-1648), phospho[Tyr1162/
1163]-Insulin Receptor (rabbit polyclonal, sc-25103), Insulin
Receptor b (goat polyclonal, sc-31369), UCP1 (goat polyclonal
sc-6529), and MyD88 (goat polyclonal, sc-8197) were from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). Antibody against ZO-
1 was from Abcam (AB96594) (Cambridge, MA). Antibodies
against phospho [Thr172]-AMPKa (rabbit polyclonal, #2531),
AMPKa (rabbit polyclonal, #2532), and IkB-a (rabbit polyclonal,
#9242) were from Cell Signaling Technology (Beverly, Massa-
chusetts, USA).
Mice
TLR2-deficient mice, also called TLR2 knockout (KO) mice,
were obtained by Dr. Akira [65] and were kindly provided by Dr.
Ricardo Gazzinelli [66] and maintained on a C57BL/6J genetic
background. Studies were carried out using male TLR2 KO mice
that were age matched with C57BL/6J and obtained from the
University of Campinas Breeding Center. C57BL/6J and the
TLR2 KO mice have the same origin and have been raised in the
same institution (UNICAMP) and in the same room, at University
of Campinas Breeding Center. The C57BL/6J strain was
generated by backcrossing mice carrying the TLR2 KO mutation
10 times to C57BL/6J inbred mice [67]. TLR2-deficient mice are
viable and fertile. The control and the knockout mice used for the
experiments were littermates, obtained from a heterozygote 6
heterozygote cross, from the same mother, from the same cage, in
order to have standard conditions for all animals. The investiga-
tion was approved by the ethics committee and followed the
university guidelines for the use of animals in experimental studies,
and experiments conform to the Guide for the Care and Use of
Laboratory Animals, published by the U.S. National Institutes of
Health (NIH publication no. 85–23 revised 1996). The animals
were maintained on 12 h/12 h artificial light-dark cycles and
housed in individual cages. Mice were randomly divided into two
groups: control, fed on standard rodent chow (3.948 kcal/Kg
21),
and HFD, fed on a rich-fat chow (5.358 kcal/Kg
21) ad libitum for
16 wk. The mice were bred under specific pathogen-free
conditions at the Central Breeding Center of the University of
Campinas.
Serum Analysis
Mice were fasted for 5 h, at which time blood was collected by
the retrobulbar intraorbital capillary plexus. Hemolysis-free serum
was generated by the centrifugation of blood using serum
separator tubes (Becton Dickinson, Franklin Lakes, New Jersey).
Serum insulin, cytokines, leptin, and adiponectin were analyzed by
ELISA kits purchased from Linco Research Inc (St. Charles,
Missouri).
Determination of NF-kB Activation
NF-kB p50 activation was determined in nuclear extracts from
muscle and adipose tissue by ELISA (89858; Pierce Biotechnol-
ogy), according to the recommendations of the manufacturer.
LPS Serum Determination
Serum LPS concentration was determined using a kit based on
a Limulus amebocyte extract (LAL kit endpoint-QCL1000;
Cambrex BioScience, Walkersville, Maryland), where samples
were diluted 1/40 to 1/100 and heated for 10 min at 70uC.
Internal control of recovery calculation was included in the
assessment.
Glucose Tolerance Test
After 6 h fasting, mice were anesthetized by an i.p. injection of
sodium amobarbital (15 mg/kg body weight), and the experiments
were initiated after the loss of corneal and pedal reflexes. After
collection of an unchallenged sample (time 0), a solution of 20%
glucose (2.0 g/kg body weight) was administered into the
peritoneal cavity. Blood samples were collected from the tail at
30, 60, 90, and 120 min for determination of glucose and insulin
concentrations [68].
Euglycaemic-Hyperinsulinaemic Clamp
After a 6-h fast, a prime continuous (3.0 mU?kg
21?min
21)
infusion of regular insulin was administered in the groups of mice
for 2 h from time 0, to raise plasma insulin and maintain it at a
steady-state plateau (90–120 min). A variable glucose infusion
(10%) was started 5 min after the beginning of the experiment and
was corrected, if necessary, to maintain euglycaemia between 5
and 6.1 mmol/l [69]. Blood samples for determination of plasma
glucose were obtained at 5-min intervals throughout the study.
Oxygen Consumption/Carbon Dioxide Production and
Respiratory Exchange Ratio Determination
Oxygen consumption/carbon dioxide production and respira-
tory exchange ratio (RER) were measured in fed animals through
an indirect open circuit calorimeter (Oxymax Deluxe System;
Columbus Instruments, Columbus, Ohio), as described previously
[70].
Measurement of Food Intake
Standard chow or HFD was given and food intake was
determined by measuring the difference between the weight of
chow given and the weight of chow at the end of a 24-h period.
This procedure was performed during 5 d, with 8-wk-old mice,
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obtaining an average of food intake per cage per day. This average
was also normalized for body weight.
4-Phenyl Butyric Acid (PBA) Treatment
PBA is a chemical chaperone and evidence suggests that it
relieves endoplasmic reticulum stress [71]. For acclimation, mice
received 100 ml phosphate buffered saline (PBS) twice daily (8 a.m.
and 6 p.m.), by gavage, for 3 d. Following the acclimation period,
PBA was administered twice daily in two divided doses (500 mg/
kg at 8 a.m. and at 6 p.m., total 1 g/kg/day) by gavage for 10 d.
Control groups received the same volume of vehicle instead of
PBA at the same treatment points [33].
SP600125 Treatment
SP600125, a potent and selective inhibitor of JNK, was
dissolved in a 7% (in PBS) Solutol HS-15 solution and
administered intraperitoneally (30 mg/kg/day) for 5 d [72].
TLR4 Inhibition
In order to inhibit the expression of TLR4, two methods were
used: pharmacological inhibition, using 2.4 mg/kg/day ethyl(6R)-
6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-car-
boxylate (TAK-242) (synthesized at the Chemistry Institute of the
University of Campinas) [73], administered daily by gavage during
5 d, and 4 nmol TLR2 antisense oligonucleotide (ASO) inhibition,
composed by 59-AGGTGGGAATGCTTTTTCAG-39 (sense)
and 59-CTGAAAAAGCATTCCCACCT-39 (antisense), adminis-
tered by two daily i.p. injections during 5 d, produced by
Invitrogen Corp. (Carlsbad, California, USA).
LPS Absorption Test
An LPS tolerance test was performed as follows: Fasted mice
were gavaged with LPS (300 mg/kg) diluted in water (100 mL) or
with water (100 mL). Blood was collected from the cava vein
60 min after gavage. Plasma was separated and frozen [11].
Intracellular Cytokine Analysis and Foxp3 Staining
The cells were obtained from the adipose tissue and analyzed by
flow cytometry. For the determination of the frequency of putative
regulatory T cells, the adipose tissue mononuclear cells were
stained for the surface marker CD4 (Percp) and after for
intracellular transcription factor Foxp3 using APC anti-mouse/
rat Foxp3 staining (eBioscience, San Diego, California). The cells
were acquired in the FACS Calibur Flow cytometer (BD) and
analyzed with FlowJo software.
Antibiotics Treatment
Four-week-old WT and TLR2 KO mice were placed on broad
spectrum antibiotics (1.0 g/L ampicillin, 1.0 g/L metronidazole,
and 0.5 g/L neomycin) in drinking water for 20 d. During this
period mice were monitored for food intake and stool microbiota
sequencing.
Culture-Based Microbial Analysis of Cecal Contents
Total aerobic and anaerobic bacteria were enumerated in
selective media and incubation conditions according to Schumann
et al. [74]. In brief, cecal samples were diluted in Ringer medium,
and total aerobic and anaerobic bacteria were investigated by
plating onto nonselective media: TSS medium (Biomerieux, Lyon,
France) for 24 to 48 h at 37uC in aerobic and anaerobic
conditions. Bacterial numbers were expressed as colony forming
units (CFU)/mg cecal content [75].
Metagenome Profile
Faeces samples were collected in metabolic cages with separated
waste collectors, frozen in liquid nitrogen, and kept at 280uC until
use. DNA was then extracted using the QIAamp DNA Stool Mini
Kit (Qiagen, Hilden, Germany) and quantified. Libraries were
synthesized from 500 ng of total DNA following the Rapid Library
Preparation Kit (Roche Applied Science, Mannheim, Germany)
instructions. These libraries were analyzed in a Bioanalyzer with a
High Sensitive DNA Kit (Agilent Technologies Inc., Santa Clara,
California, USA), and equimolar pools were made, titrated, and
submitted to large volume PCR, following the manufacturer’s
instructions (Roche Applied Science, Mannheim, Germany).
Subsequently, samples were sequenced in GS FLX Titanium,
using a GS FLX Titanium PicoTiterPlate Kit combined with a GS
FLX Titanium Sequencing Kit XLR70 (Roche Applied Science,
Mannheim, Germany). The data obtained from the sequencing
were submitted to the MG-RAST server and compared by
phylum prevalence among groups [76].
Microbiota Transplantation
Cecal contents were pooled from 3 TLR2 KO mice and age-
and gender-matched WT littermates. Cecal extracts were
suspended in PBS (2.5 ml per cecum) and were administered
(0.1 ml per mouse) immediately to sterilely packed, 4-wk-old,
Bacillus-associated, WT mice that were obtained from the Central
Breeding Center of the State University of Campinas. Trans-
planted mice were maintained in sterile cages and monitored for
body weight [30].
Tissue Extraction, Immunoprecipitation, and
Immunoblotting
Mice were anesthetized by intraperitoneal injection of sodium
thiopental and used 10–15 min later—i.e., as soon as anesthesia
was assured by the loss of pedal and corneal reflexes. In some
experiments, 3 or 5 min after insulin injection (3.8 units/kg,
intraperitoneally), liver or muscle and white adipose tissue were
removed, respectively, and homogenized immediately in extrac-
tion buffer at 4uC (1% Triton X-100, 100 mM Tris-HCl (pH 7.4),
100 mM sodium pyrophosphate, 100 mM sodium fluoride, 10 mM
EDTA, 10 mM sodium orthovanadate, 2.0 mM phenylmethylsul-
fonyl fluoride, and 0.1 mg of aprotinin/ml) with a Polytron PTA
20 S generator (model PT 10/35; Brinkmann Instruments).
Insoluble material was removed by centrifugation for 30 min at
9,0006g in a 70 Ti rotor (Beckman, Fullerton, California) at 4uC.
The protein concentrations of the supernatants were determined
by the Bradford dye binding method. Aliquots of the resulting
supernatants containing 1.0 mg of total protein were used for
immunoprecipitation with antibodies against MyD88 overnight at
4uC, followed by SDS-PAGE, transfer to nitrocellulose mem-
branes, and blotting with anti-TLR4. In direct immunoblot
experiments, 0.2 mg of protein extracts were separated by SDS-
PAGE, transferred to nitrocellulose membranes, and blotted with
anti-UCP1, anti-phospho-JNK, anti-IkBa, anti-phospho-PERK,
anti-phospho-AKT, anti-phospho [Ser307]-IRS-1, anti-phospho
[Tyr941]-IRS-1 (Tyr), anti-phospho-IR, anti-ZO-1, anti-PGC-1a,
anti-phospho [Thr171]-AMPK, and anti-IkB-a. The homogeneity
of gel loading was always evaluated by blotting the membranes
with antibodies against b-actin, IRS-1, AKT, IR, JNK, PERK,
and AMPK as appropriate.
Statistical Analysis
Specific protein bands present on the blots were quantified by
densitometry. Mean 6 S.E. values obtained from densitometric
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Student’s t test for paired samples or by repeat-measure analysis of
variance (one-way or two-way analysis of variance) followed by
post hoc analysis of significance (Bonferroni test) when appropri-
ate. When analyzing non-linear parameters, we used Mann-
Whitney test. A p,0.05 was accepted as statistically significant.
Supporting Information
Figure S1 Taxonomical characterization of WT gut microbiota.
Untreated WT stools were analyzed via 16S rRNA analysis.
(TIF)
Figure S2 TLR2 KO mice exhibit taxonomical alterations in
gut microbiota. TLR2 knockout (TLR22/2) mice stools were
analyzed via 16S rRNA analysis.
(TIF)
Figure S3 Bacterial phyla distribution in 4-wk-old-WT (A) or –
TLR22/2 mice (B). These analyses were obtained by 16S rRNA
sequencing.
(TIF)
Figure S4 Bacterial phyla distribution in 16-wk-old-WT (A) or –
TLR22/2 mice (B). These analyses were obtained by 16S rRNA
sequencing.
(TIF)
Figure S5 Bacterial phyla distribution in 1-y-old-WT (E) or –
TLR22/2 mice (F). These analyses were obtained by 16S rRNA
sequencing.
(TIF)
Figure S6 Phosphorylation of the insulin receptor in muscle (A),
liver (B), and white adipose tissue (WAT) (C). Tyrosine 172
phosphorylation of AMPK in muscle (D), liver (E), and WAT (F).
PGC-1a expression in muscle (G), liver (H), and WAT (I). Insulin
receptor and AMPK protein expression in muscle, liver, and WAT
(lower panels). Equal protein loading in the gel was confirmed by
reblotting the membrane with an anti-b-actin antibody (lower
panels). Data are presented from six to eight mice per group, from
experiments that were repeated at least three times. All evaluations
were made with mice on standard chow. * p,0.05 between WT
mice with or without insulin stimulus; ** p,0.05 between WT and
TLR22/2 mice with insulin stimulus.
(TIF)
Figure S7 Cecal samples of TLR2 knockout (TLR22/2) mice
were cultured in aerobic and anaerobic environments with or
without the treatment with a mixture of antibiotics (AB) (0.5 g/kg
neomycin, 1 g/kg metronidazole, and 1.0 g/kg ampicillin).
Aerobic bacteria counts went below the detection limit in the
groups treated with the AB. TLR2 knockout (TLR22/2) mice
exhibit taxonomical alterations in gut microbiota after the
treatment with a mixture of AB (C), compared with controls,
without antibiotics treatment (B). Mice stools were analyzed via
16S rRNA analysis. Data are presented from six to eight mice per
group, from experiments that were repeated at least three times.
All evaluations were made with mice on standard chow. * p,0.05
between aerobic bacteria of TLR22/2 mice with or without AB
treatment; ** p,0.05 between anaerobic bacteria of TLR22/2
mice with or without AB treatment.
(TIF)
Figure S8 Taxonomical characterization of WT gut microbiota
after the treatment with a mixture of antibiotics (AB) (0.5 g/kg
neomycin, 1 g/kg metronidazole, and 1.0 g/kg ampicillin).
WT+AB stools were analyzed via 16S rRNA analysis.
(TIF)
Figure S9 Taxonomical characterization of TLR22/2 gut
microbiota after the treatment with a mixture of antibiotics (AB)
(0.5 g/kg neomycin, 1 g/kg metronidazole, and 1.0 g/kg ampi-
cillin). TLR22/2 + AB stools were analyzed via 16S rRNA
analysis.
(TIF)
Figure S10 Taxonomical alteration obtained from the treatment
with antibiotics individually (0.5 g/kg neomycin, 1 g/kg metroni-
dazole, and 1.0 g/kg ampicillin). TLR22/2 mice treated only
with metronidazole (A). TLR22/2 mice treated only with
neomycin (B). TLR22/2 mice treated only with ampicillin (C).
(TIF)
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